Examines the molecular basis for altered signal transduction in patients with disordered G protein function (e.g. pseudohypoparathyroidism type 1a and McCune Albright syndrome), patients with abnormal PTH receptor function (e.g. pseudohypoparathyroidism type 1b), and patients with abnormal PTH function (e.g. Familial Isolated Hypoparathyroidism).
Showing the most recent 10 out of 749 publications